Suppr超能文献

奈替米星、阿米卡星、妥布霉素和西索米星对庆大霉素高度耐药肠杆菌科细菌的体外活性比较

Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae.

作者信息

Tselentis J, Legakis N J, Nicolas K J, Melissinos K, Papavassiliou J

出版信息

Chemotherapy. 1980;26(6):409-17. doi: 10.1159/000237936.

Abstract

Netilmicin was compared with sisomicin, tobramycin and amikacin against 65 recent clinical enterobacterial isolates found to be highly resistant to gentamicin (MIC larger than or equal to 80 microgram/ml). Netilmicin showed a high activity against 20 out of 65 strains tested. Most of the sensitive strains (60%) to netilmicin required a concentration of gentamicin equal or lower than 160 microgram/ml for inhibition. Amikacin proved to be extremely effective in all the organisms tested. Tobramycin was consistently less active than either netilmicin or amikacin and the same was the case with sisomicin. The MIC was determined in both solid and liquid media for 24 strains. Depending upon which aminoglycoside was used, we found that 10-30% of the enterobacteriaceae exhibited a twofold diminution of MIC when tested in broth as compared to agar, while the greater proportion of strains was characterized by a higher MIC tested in broth as compared to agar.

摘要

将奈替米星与西索米星、妥布霉素和阿米卡星进行比较,以观察它们对65株近期临床分离出的对庆大霉素高度耐药(最低抑菌浓度大于或等于80微克/毫升)的肠杆菌的抗菌效果。奈替米星对65株测试菌株中的20株显示出高活性。大多数对奈替米星敏感的菌株(60%)抑制所需的庆大霉素浓度等于或低于160微克/毫升。阿米卡星在所有测试的菌株中均显示出极高的有效性。妥布霉素的活性始终低于奈替米星或阿米卡星,西索米星也是如此。对24株菌株在固体和液体培养基中均测定了最低抑菌浓度。根据所使用的氨基糖苷类药物不同,我们发现,与琼脂培养基相比,10% - 30%的肠杆菌科细菌在肉汤培养基中测试时最低抑菌浓度降低了两倍,而更大比例的菌株其在肉汤培养基中测试时最低抑菌浓度高于琼脂培养基中的测试结果。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验